Shingles Vaccine Market is expected to See Huge Growth by 2023-2030 with Top Players Zostavax, Shingrix

Description:

The Zostavax vaccine is a live attenuated vaccine that contains a weakened form of the herpes zoster virus, which causes shingles. The vaccine works by stimulating the body's immune system to produce a protective response against the virus, thereby reducing the risk of developing shingles. The effectiveness of the Zostavax vaccine varies depending on the age group. According to clinical trials, the vaccine was found to be 64% effective in people aged 60 to 69 years, but this effectiveness decreases with increasing age. In those aged 70 to 79 years, the effectiveness of the vaccine was found to be 41%, and in those aged 80 years and above, the effectiveness was only 18%.

The Zostavax vaccine was launched in the Indian market in February 2016 at half the price of the U.S. market. It is the only shingles vaccine in the market and recorded sales of US$ 749 million in 2015. It is important to note that the Zostavax vaccine is not recommended for everyone. It is specifically intended for use in people aged 50 years and above who are not immunocompromised, do not have a history of allergic reactions to the vaccine, and have not had shingles before. People who are immunocompromised or have a weakened immune system should not receive the vaccine. Additionally, the Zostavax vaccine is not 100% effective in preventing shingles, and some people may still develop the disease even after receiving the vaccine.

Click Here to Request a Sample Copy with More Details: -https://www.coherentmarketinsights.com/insight/request-sample/73

** Note - This Report Sample Includes:

➣ Brief Overview to the research study.

➣ Table of Contents The scope of the study's coverage

➣ Leading market participants

➣ Structure of the report's research framework

➣ Coherent Market Insights' research approach

Top Key Players are Covered in this Report:

★ GlaxoSmithKline plc.
★ Merck & Co., Inc.
★ SK chemicals
★ Green Cross Corp
★ Geneone Life Science
★ Vaccitech
★ CanSinoBIO

Shingles Vaccine Market: Segment Analysis

By Drug

Zostavax
Shingrix
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy and Others

By Geography

North America (USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

The Key Findings of the Report:

✍ This report describes the various situations of the entire market and provides a roadmap for how Shingles Vaccine industry participants can gain a foothold in this rapidly changing market. Industry participants can reform their strategies and methods by checking the market size forecast mentioned in this report. The profitable segments/subsegments for the Shingles Vaccine market have been revealed, which may affect the expansion strategy of leading organizations. However, this research report has detailed information about each manufacturer.

✍ The chapter on the analysis of key factors in the market focuses on technological progress/risks, substitution threats, changes in consumer demand/customer preferences, technological progress in related industries, and changes in the economic/political environment that attract market growth factors.

✍ The research points to the fastest and slowest growing market segments to provide important insights into each core element of the market. New market participants started trading and accelerated the transition in the Shingles Vaccine market. M&A activity is predicted to change the market structure of the industry.

Highlight the Following Key Factors:

Business description: a detailed description of company operations and business departments.

Company strategy: The analyst's summary of the company's business strategy.

SWOT Analysis: Detailed analysis of the company's strengths, weaknesses, opportunities, and threats.

Company History: The progress of major events related to the company.

Main products and services: A list of the company's main products, services, and brands.

Main competitors: A list of the company's main competitors.

Important locations and subsidiaries: The company's main locations and subsidiaries' list and contact information.

Detailed financial ratios of the past five years: The latest financial ratios come from the annual financial statements issued by companies with a history of five years.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 This Complete Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/73

Reasons to Buy this Report:

⏩ Upgrade your market research resources with this comprehensive and accurate report on the Shingles Vaccine market

⏩ Get a complete understanding of general market scenarios and future market situations to prepare for rising above the challenges and ensuring strong growth

⏩ It provides a detailed analysis of changing market trends, current and future technologies used, and various strategies adopted by leading players of the Shingles Vaccine market

⏩ It offers recommendations and advice for new entrants in the Shingles Vaccine market and carefully guides established players for further market growth

⏩ Apart from the hottest technological advances in the Shingles Vaccine market, it brings to light the future plans of dominant players in the industry

Table of Contents with Major Points:

1. Executive Summary
1.1. Market Snapshot
1.2. Segmental Market Estimates & Forecasts, 2023-2030 (USD Billion)
1.2.1. Shingles Vaccine Market, by Region, 2023-2030 (USD Billion)
1.2.2. Shingles Vaccine Market, by Type, 2023-2030 (USD Billion)
1.2.3. Shingles Vaccine Market, by Application, 2023-2030 (USD Billion)
1.2.4. Shingles Vaccine Market, by Verticles, 2023-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

2. Shingles Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

3. Shingles Vaccine Market Dynamics
3.1. Shingles Vaccine Market Impact Analysis (2023-2030)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities

4. Shingles Vaccine Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2023-2030)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

5. Shingles Vaccine Market, by Type
5.1. Market Snapshot
5.2. Shingles Vaccine Market by Type, Performance - Potential Analysis
5.3. Shingles Vaccine Market Estimates & Forecasts by Type 2023-2030 (USD Billion)
5.4. Shingles Vaccine Market, Sub-Segment Analysis

6. Shingles Vaccine Market, by Application
6.1. Market Snapshot
6.2. Shingles Vaccine Market by Application, Performance - Potential Analysis
6.3. Shingles Vaccine Market Estimates & Forecasts by Application 2023-2030 (USD Billion)
6.4. Shingles Vaccine Market, Sub-Segment Analysis
6.4.1. Others

7. Shingles Vaccine Market, by Verticles
7.1. Market Snapshot
7.2. Shingles Vaccine Market by Verticles, Performance - Potential Analysis
7.3. Shingles Vaccine Market Estimates & Forecasts by Verticles 2023-2030 (USD Billion)
7.4. Shingles Vaccine Market, Sub-Segment Analysis

8. Shingles Vaccine Market, Regional Analysis
8.1. Shingles Vaccine Market, Regional Market Snapshot
8.2. North America Shingles Vaccine Market
8.3. Europe Shingles Vaccine Market Snapshot
8.4. Asia-Pacific Shingles Vaccine Market Snapshot
8.5. Latin America Shingles Vaccine Market Snapshot
8.6. Rest of The World Shingles Vaccine Market

9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Key Player
9.2.1.1. Key In Duration
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments

10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes

Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/73

Contact Us :

Mr. Shah

Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States.
📞 U.S.A: +1-206-701-6702
📞 UK: +44-020-8133-4027
📞 JAPAN: +050-5539-1737
📞 India: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com
🌐 Website: https://www.coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for CMI clientele spread across different enterprises. We at Coherent are obliged to serve CMI diverse customer base present across the industries of healthcare, technology, semiconductors and chemicals among various other industries present around the world. We strive to provide CMI' customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Coherent endeavor to deliver value-added business solutions to CMI's customers.

This release was published on openPR.